Powered by Bioz
FDA clearance brings liquid biopsy into a new era
With the FDA clearance of several assays, liquid biopsy moves closer toward the goal of making this screening method a standard of care. Liquid biopsy…
Read More Cell-Free DNA BCT®
For In Vitro Diagnostic Use
Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization and transport of venous whole blood samples for use in conjunction with cell-free DNA next generation sequencing liquid biopsy assays that have been cleared or approved for use with samples collected in the Cell-Free DNA BCT device.
Performance characteristics of this device have only been established on the Guardant360® CDx assay.
Product Description
Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization and transport of venous whole blood samples for use in conjunction with cell-free DNA next generation sequencing liquid biopsy assays that have been cleared or approved for use with samples collected in the Cell-Free DNA BCT device.
Cold chain free – Transport samples at room temperature
Ordering Information
| Description | Catalog Number |
|---|---|
| 6-tube pack (10.0 mL) – 16mm x 100mm | 230469 |
| 100-tube box (10.0 mL) – 16mm x 100mm | 230470 |
| 1000-tube case (10.0 mL) – 16mm x 100mm | 230471 |
Order Cell-Free DNA BCT today
New customers
Existing customers
Citations
Resources
Instructions (IFU)
Product Information
Certificates
- Cell-Free DNA BCT IVD CoA Lot 2224 2023-10-04
- Cell-Free DNA BCT IVD CoA Lot 2270 2023-10-25
- Cell-Free DNA BCT IVD CoA Lot 2278 2023-11-09
- Cell-Free DNA BCT IVD CoA Lot 2311 2024-01-11
- Cell-Free DNA BCT IVD CoA Lot 2340 2024-02-15
- Cell-Free DNA BCT IVD CoA Lot 2347 2024-02-22
- Cell-Free DNA BCT IVD CoA Lot 3009 2024-03-19
- Cell-Free DNA BCT IVD CoA Lot 3051 2024-04-17
- Cell-Free DNA BCT IVD CoA Lot 3056 2024-05-07
- Cell-Free DNA BCT IVD CoA Lot 3076 2024-06-22
- Cell-Free DNA BCT IVD CoA Lot 3089 2024-06-29
- Cell-Free DNA BCT IVD CoA Lot 3124 2024-07-16
- Cell-Free DNA BCT IVD CoA Lot 3138 2024-08-06
- Cell-Free DNA BCT IVD CoA Lot 3166 2024-09-27
- Cell-Free DNA BCT IVD CoA Lot 3194 2024-10-24
Looking for an older document? Click here for archived assays and certificates.
Stabilization Products
Streck’s patented portfolio of stabilization solutions enables scientists to mitigate and limit pre-analytical variation in critical samples, ease handling concerns and allow for room temperature storage, cold chain-free shipping and batch processing. Our direct draw blood collection tubes and preservation products for biofluids are recognized worldwide. Target analytes include cell-free DNA, cell-free RNA, clusters of differentiation antigens, extracellular vesicles and cellular nucleic acids.
The latest from the blog
Stabilization
Stabilization
How can nucleic acids predict disease?
Liquid biopsy is a diagnostic technique where bodily fluids are examined for biomarkers that suggest disease. In recent years, liquid biopsy has been …
Read More 
Stabilization
Why does stabilization matter?
Human blood is packed with genetic information found in circulating cell-free DNA (cfDNA) and cell-free RNA (RNA). Liquid biopsy takes advantage of th…
Read More 